Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
In Brief

UCSD receives $16M NIH FIRST Award to recruit 12 diverse, early-career researchers

UC San Diego has received a five-year, $16 million grant from NIH Common Fund’s Faculty Institutional Recruitment for Sustainable Transformation Program will enable the University of California San Diego to recruit 12 diverse, early-career research faculty in the biomedical sciences. This is the largest grant received by UC San Diego to enhance faculty diversity.
September 23, 2022
Vol.48 No.34
In Brief

UCSD to lead components of NIH Common Fund’s Bridge to Artificial Intelligence program

Researchers at University of California San Diego School of Medicine have been selected to lead components of the NIH Common Fund’s Bridge to Artificial Intelligence program.
September 23, 2022
Vol.48 No.34
In Brief

Noe Crespo named co-leader of cancer control at Moores Cancer Center UCSD

Noe Crespo was named co-leader of the Cancer Control Program at University of California San Diego’s Moores Cancer Center.
February 04, 2022
Vol.48 No.05

Posts navigation

Previous123

Trending Stories

  • Lou Weiner: Poetry and art help us imagine my mother’s world as a hidden child of the Holocaust
  • ACOG says it will no longer accept federal funding
  • GOP-led Congress rejects Trump’s plans to gut medical research
    Senate bill gives NIH a $400 million raise
  • Vinay Prasad falls from grace at FDA upon flunking Trump political purity test
    MAHA leaders agree on one point: COVID was mishandled. Is that enough to run science-based agencies?
  • Andrea Werblin Reid’s unflinching poetry documents the realities of cancer care, clinical trials, and loss
    Her collection, “To See Yourself As You Vanish,” will be published three years after her death
  • Brown University reaches agreement with Trump administration to restore funding

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2025 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation
Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account